07 January,2024 08:55 AM IST | Washington | IANS
Image for representational purposes only. Photo Courtesy: iStock
Hydroxychloroquine (HCQ) recommended by physicians for curing Covid-19 has been linked to nearly 17,000 deaths, according to a new study as quoted by media reports.
A new study conducted by French researchers has found that nearly 17,000 people across six countries may have died after being prescribed hydroxychloroquine (HCQ) while hospitalised with illness from March to July 2020 during the first wave of Covid-19, Newsweek reported.
During the Covid-19 pandemic, former US President Donald Trump urged Americans to take hydroxychloroquine (HCQ), an anti-malaria medicine that is also often used to cure rheumatoid arthritis and lupus, claiming that he himself had been taking the "miracle" drug.
The research published in the February issue of Biomedicine & Pharmacotherapy shows that increase in the number of deaths was driven by side effects like heart arrhythmia and muscle weakness.
ALSO READ
Two Gujarat hospitals de-panelled, 2 slapped with fines for irregularities under health scheme
Karnataka Health Minister to discuss 'high-level' probe with CM over maternal deaths
Here’s how Singga battled depression and found healing in the gym
Health explainer: What is idiopathic pulmonary fibrosis and its effects?
NEET exam mode under review: decision expected soon, says Pradhan
The countries studied were the US, Turkey, Belgium, France, Spain and Italy, Newsweek reported.
The US reported the highest numbers of deaths with 12,739, followed by Spain (1,895), Italy (1,822), Belgium (240), France (199) and Turkey (95).
The researchers said that the number of deaths could be much higher as their study only looked at only six countries between March and July 2020.
The scientists analysed various studies that tracked hospitalisations due to Covid-19 and exposure to the drug and risk related to it.
After the outbreak of coronavirus, scientists suggested that HCQ could be effective in treating the deadly virus, Newsweek reported.
On March 28, 2020, the Food and Drug Administration (FDA) approved the drug for an emergency use authorisation and started clinical trials.
However in June 2020, the FDA revoked the emergency use authorisation of the drug as several studies, including one by New England Journal of Medicine, found HCQ had no benefit on Covid and led to significant surge in the risk of death. The FDA revoked the emergency use authorisation on June 15, 2020.
While one scientist called the HCQ a "magic bullet" against coronavirus, Trump highlighted the "miracle" recovery made by a Covid-infected woman after using the drug, Newsweek reported.
"The nice part is, it's been around for a long time...if things don't go as planned, it's not going to kill anybody," the ex-US President Trump said during a Covid Taskforce briefing.
In a tweet on March 21, 2020, he added that "FDA has moved mountains" and that the drug would be put to use "immediately" as an antidote to curb Covid transmission.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever